FIDIAFF

FIDIA

0.0106EURD
+0.0002+1.92%
At close at 16:53 GMT
EUR
No trades
See on Supercharts

FDA fundamentals

FIDIA financial statements, including revenue, expenses, and profit

The total revenue of FDA for the last semiannual is 9.42 M EUR, and it's 51.98% lower compared to the previous semiannual. The net income of H1 24 is -7.21 M EUR.

H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
‪‪−8.00 M‬‬
‪0.00‬
‪‪8.00 M‬‬
‪‪16.00 M‬‬
‪‪24.00 M‬‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
H1 '22
Jun 2022
H2 '22
Dec 2022
H1 '23
Jun 2023
H2 '23
Dec 2023
H1 '24
Jun 2024
TTM
Total revenueYoY growth
‪‪9.44 M‬‬
‪‪14.93 M‬‬
‪‪8.99 M‬‬
−4.74%
‪‪19.62 M‬‬
+31.39%
‪‪9.42 M‬‬
+4.81%
‪‪29.04 M‬‬
‪‪−9.32 M‬‬
‪‪−13.60 M‬‬
‪‪−8.04 M‬‬
‪‪−15.43 M‬‬
‪‪−8.92 M‬‬
‪‪−24.35 M‬‬
Gross profitYoY growth
‪‪113.00 K‬‬
‪‪1.33 M‬‬
‪‪951.00 K‬‬
+741.59%
‪‪4.19 M‬‬
+213.86%
‪‪497.00 K‬‬
−47.74%
‪‪4.69 M‬‬
‪‪−2.71 M‬‬
‪‪−4.05 M‬‬
‪‪−3.27 M‬‬
‪‪−3.98 M‬‬
‪‪−3.04 M‬‬
‪‪−7.02 M‬‬
‪‪−2.60 M‬‬
‪‪−2.72 M‬‬
‪‪−2.31 M‬‬
+10.79%
‪‪209.00 K‬‬
‪‪−2.55 M‬‬
−9.98%
‪‪−2.34 M‬‬
‪‪11.04 M‬‬
‪‪−183.00 K‬‬
‪‪269.00 K‬‬
‪‪612.00 K‬‬
‪‪−4.65 M‬‬
‪‪−4.04 M‬‬
Pretax incomeYoY growth
‪‪8.45 M‬‬
‪‪−2.90 M‬‬
‪‪−2.05 M‬‬
−124.21%
‪‪821.00 K‬‬
‪‪−7.19 M‬‬
−251.56%
‪‪−6.37 M‬‬
‪0.00‬
‪0.00‬
‪0.00‬
‪‪18.00 K‬‬
‪‪188.00 K‬‬
‪‪−135.00 K‬‬
‪‪−113.00 K‬‬
‪‪−49.00 K‬‬
‪‪−162.00 K‬‬
‪‪111.00 K‬‬
‪‪103.00 K‬‬
‪‪97.00 K‬‬
‪‪69.00 K‬‬
‪‪27.00 K‬‬
‪‪96.00 K‬‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪‪8.58 M‬‬
‪‪−2.61 M‬‬
‪‪−2.08 M‬‬
‪‪777.00 K‬‬
‪‪−7.21 M‬‬
‪‪−6.44 M‬‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
Net incomeYoY growth
‪‪8.58 M‬‬
‪‪−2.61 M‬‬
‪‪−2.08 M‬‬
−124.29%
‪‪777.00 K‬‬
‪‪−7.21 M‬‬
−246.21%
‪‪−6.44 M‬‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪‪8.58 M‬‬
‪‪−2.61 M‬‬
‪‪−2.08 M‬‬
‪‪777.00 K‬‬
‪‪−7.21 M‬‬
‪‪−6.44 M‬‬
‪1.68‬
‪−0.38‬
‪−0.30‬
−117.92%
‪0.11‬
‪−0.32‬
−6.52%
‪−0.21‬
‪1.68‬
‪−0.38‬
‪−0.30‬
−117.92%
‪0.11‬
‪−0.32‬
−6.52%
‪−0.21‬
‪‪5.11 M‬‬
‪‪6.93 M‬‬
‪‪6.93 M‬‬
‪‪6.93 M‬‬
‪‪22.53 M‬‬
‪‪5.11 M‬‬
‪‪6.93 M‬‬
‪‪6.93 M‬‬
‪‪6.93 M‬‬
‪‪22.53 M‬‬
EBITDAYoY growth
‪‪−1.73 M‬‬
‪‪−1.84 M‬‬
‪‪−1.66 M‬‬
+3.99%
‪‪838.00 K‬‬
‪‪−2.00 M‬‬
−20.28%
‪‪−1.16 M‬‬
EBITYoY growth
‪‪−2.60 M‬‬
‪‪−2.72 M‬‬
‪‪−2.31 M‬‬
+10.79%
‪‪209.00 K‬‬
‪‪−2.55 M‬‬
−9.98%
‪‪−2.34 M‬‬
‪‪−12.03 M‬‬
‪‪−17.65 M‬‬
‪‪−11.30 M‬‬
‪‪−19.41 M‬‬
‪‪−11.97 M‬‬
‪‪−31.38 M‬‬